MedPath

Dosimetric Evaluation of Breathing Impact on PTV and Adjacent Organ At Risk in Breast Cancer Radiotherapy

Active, not recruiting
Conditions
Breast Cancer
Registration Number
NCT07048639
Lead Sponsor
Superior University
Brief Summary

The study is likely an observational study, possibly retrospective or prospective, involving patients with breast cancer undergoing radiotherapy.

Detailed Description

Patients with breast cancer scheduled for radiotherapy will be selected based on specific inclusion and exclusion criteria.

Patients will undergo imaging studies, such as computed tomography (CT) scans, to define the target volumes and OARs.

The study aims to provide insights into the dosimetric impact of breathing motion on PTV and OARs in breast cancer radiotherapy, which can inform strategies to improve treatment planning and delivery.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
22
Inclusion Criteria
  • Patient of breast cancer.
  • age 25-40
Exclusion Criteria
  • Patients without breast cancer

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Physician's Global Assessment (PGA) Scale with scoring details12 Months

The Physician's Global Assessment (PGA) scale is a tool used by physicians to evaluate the overall severity of a patient's disease. It's a subjective assessment, typically on a scale of 0 to 3 or 0 to 4, with higher scores indicating more severe disease activity. The PGA focuses on the overall disease activity, considering both the severity of active manifestations and relevant laboratory results, excluding organ damage and subjective findings unrelated to disease activity.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

INMOL hospital

🇵🇰

Lahore, Punjab, Pakistan

INMOL hospital
🇵🇰Lahore, Punjab, Pakistan

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.